Co-administration of CART22-65s and huCART19 for B-ALL

Clinical trial NCT05674175 · RECRUITING

Trial details

NCT number: NCT05674175
Sponsor: Stephan Grupp MD PhD
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia B Lineage Lymphoblastic Lymphoma

Start date: 2023-01-25
Primary completion: 2028-07-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.